The GLP is committed to full transparency. Download and review our 2019 Annual Report

Biotechnology must remain part of EU-US trade negotiations

| June 19, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an editorial summary.

The United States and European Union are in the process of negotiating a sweeping free-trade agreement, but the EU’s long-standing suspicion of and heavy restrictions on genetically modified crops presents a sticking point for what could be a massive boost to the US and EU economies.

Farmer John Reifsteck frames the issue:

Here in the United States, our science-based regulations approve biotechnology as a safe tool of sustainable agriculture[…] In Europe, however, everything is political, including the regulatory process that controls what products farmers can use. Many scientific groups in Europe, such as Britain’s Royal Society, have endorsed GM crops[…] Yet European governments ignore these recommendations, preferring to let anti-biotech activists drive consumer ignorance and dictate policies.

So GM crops have become a major area of transatlantic disagreement—a non-tariff barrier to healthy commerce in food.

But we must not take biotechnology off the table, he argues: “Rather than taking biotechnology off the table, let’s make it a centerpiece.”

Read the full story here: Don’t Allow Biotechnology to be Taken Off the EU-US Negotiating Table

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend